Beilstein J. Nanotechnol.2025,16, 1711–1733, doi:10.3762/bjnano.16.120
required to produce nanoemulsions with a uniform particle size and incorporated a co-surfactant to enhance the stability of the nanoformulation. A straightforward method was proposed, involving the dilution of the preformulation in an ophthalmicvehicle, followed by homogenization through ultrasonication
efficacy and safety for ocular administration.
Keywords: eye drops; micelles; low-energy method; ophthalmicvehicle; sample dilution; stability; Introduction
Dry eye disease (DED) is a multifactorial condition affecting the ocular surface, characterized by changes in tear fluid composition and/or
conducted to determine (1) the appropriate amounts of surfactant in the pre-emulsions, (2) the nanoformulation prepared in an ophthalmicvehicle (OV), and (3) its stabilization with a co-surfactant. The formulations prepared in the OV were sterilized using a polyethersulfone (PES) membrane filter (0.22 μm
PDF
Figure 1:
Linseed oil (Sigma-Aldrich®): (a) image of the oil after heating to 75 °C and (b) TGA/DSC curves.